Management of Chronic HBV Infection in Children

  • Md Rukunuzzaman
  • Md Benzamin
  • Kaniz Sultana


Hepatitis B virus (HBV) infection is prevalent worldwide. About ten million people are chronically infected with HBV in Bangladesh, and it is possible that most infections occur during childhood. Overall prevalence is about 3% in Bangladesh. Chronic hepatitis B infection evolves through five phases. Most of the children belong to the immune-tolerant phase. Treatment of chronic hepatitis B is difficult. The goals of therapy are to reduce viral replication, to minimize liver injury, to reduce consequence of liver injury like cirrhosis and hepatocellular carcinoma, and to reduce infectivity of HBV. Treatment should be considered in chronic hepatitis B if patients have persistently elevated ALT of more than twice the normal range and evidence of viral replication. Seroconversion occurs in about 17–32% of cases if treated with oral nucleot(s)ide analogue and in about 58% of cases if treated with interferon. Risk factor identification and prevention of HBV infection is the logical and rational approach.


Chronic hepatitis B Children 


  1. 1.
    World Health Organization. Hepatitis B. 2002. pp. 6–75. Retrieved January 2, 2008, from
  2. 2.
    Ahmad N, Alam S, Mustafa G, Adnan ABM, Baig RH, Khan M. Hepatitis e antigen negative chronic hepatitis B in Bangladesh. HBPD Int. 2008;7:379–82.PubMedGoogle Scholar
  3. 3.
    Zaki MH, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemiology of hepatitis B and Delta virus infection in Bangladesh. J Trop Paediatr. 2003;49:371–4.CrossRefGoogle Scholar
  4. 4.
    Laskar MS, Harada N, Khan F. Prevalence of hepatitis B surface antigen in Viqarunnessa noon Girls’school children in Dhaka, Bangladesh. Centr Eur J Public Health. 1997;5:202–4.Google Scholar
  5. 5.
    Jamal CY, Rahman SA, Kawser CA. Prevalence of HBV markers in multi-transfused thalassaemic patients. Bangladesh J Child Health. 1997;21:38–42.Google Scholar
  6. 6.
    Akhter S, Talukder MQK, Bhuiyan N, Chowdhury TA, Islam MN, Begum S. Hepatitis B virus infection in pregnant mothers and its transmission to infants. Indian J Pediatr. 1992;59:411–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Hochman JA, Balistreri WF. Acute and chronic viral hepatitis. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. New York: Cambridge University Press; 2007. p. 382–406.Google Scholar
  8. 8.
    Rukunuzzaman M, Afroza A. Study of risk factors of hepatitis B virus infection in children. Mymensingh Med J. 2011;20:700–8.PubMedGoogle Scholar
  9. 9.
    Mahtab MA, Rahman S, Karim MF, Khan M, Foster G, Solaiman S, et al. Epidemiology of hepatitis B virus in Bangladeshi general population. HBPD Int. 2008;7:595–600.PubMedGoogle Scholar
  10. 10.
    Sali S, Bashter R, Alavian SM. Risk factors in chronic hepatitis B infection: a case control study. Hepat Mon. 2005;5:109–15.Google Scholar
  11. 11.
    Alam MS, Khatoon S, Rima R, Afrin S. The seroprevalence of HBV among children attending urban & rural hospitals. Bangladesh J Child Health. 2006;30:17–21.Google Scholar
  12. 12.
    Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.CrossRefPubMedGoogle Scholar
  13. 13.
    Chakravarti A, Rawat D, Jain M. A study on perinatal transmission of the hepatitis B virus. IJMM. 2005;23:128–30.PubMedGoogle Scholar
  14. 14.
    Batayneh N, Bdour S. Risk of perinatal transmission of the hepatitis B virus in Jordan. Infect Dis Obstet Gynecol. 2002;10:127–32.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li X, et al. Breastfeeding ofnewborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med. 2011;165:837–46.CrossRefPubMedGoogle Scholar
  16. 16.
    World Health Organization. Hepatitis B and breastfeeding. World Health Organization. JIAPAC. 1998;4:20–1.Google Scholar
  17. 17.
    Kerkar N. Hepatitis B in children: complexities in management. Paediatr Transplant. 2005;9:685–91.CrossRefGoogle Scholar
  18. 18.
    European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–85.CrossRefGoogle Scholar
  19. 19.
    Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and nutrition. J Hepatology. 2013;59:814–29.CrossRefGoogle Scholar
  20. 20.
    Giacchino R, Cappelli B. Treatment of viral hepatitis B in children. Expert Opin Pharmacother. 2010;11:889–903.CrossRefPubMedGoogle Scholar
  21. 21.
    Satapathy SK, Garg S, Chauhan R, Malhotra V, Sakhuja P, Sharma BC, et al. Profile of chronic hepatitis B virus in children in India: experience with 116 children. J Gastroenterol Hepatol. 2006;21:1170–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Rapti IN, Hadziyannis SJ. Treatment of special populations with chronic hepatitis B infection. Expert Rev Gastroenterol Hepatol. 2011;5:323–39.CrossRefPubMedGoogle Scholar
  23. 23.
    Schwarz KB, Mohan P, Narkewicz MR, Molleston JP, Nash SR, Hu S, et al. Safety, efficacy and pharmacokinetics of Peginterferon alpha 2a in children in chronic hepatitis C. J Pediatr Gastroenterol Nutr. 2006;43:499–505.CrossRefPubMedGoogle Scholar
  24. 24.
    Yuen MF, Lai CL. Treatment of chronic hepatitis B: evolution over two decades. J Gastroenterol Hepatol. 2011;26:138–43.CrossRefPubMedGoogle Scholar
  25. 25.
    Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. J Hepatol. 2012;57:885–96.CrossRefPubMedGoogle Scholar
  26. 26.
    Rukunuzzaman M, Afroza A. Clinical, biochemical and Virological profile of chronic hepatitis B virus infection in children. Mymensingh Med J. 2012;21:120–3.PubMedGoogle Scholar
  27. 27.
    Chang TT, Gish RG, de Man R. A comparison of entecavir and lamivudine for HBeAg positive chronic hepatitis B. N Engl J Med. 2006;354:1001–10.CrossRefPubMedGoogle Scholar
  28. 28.
    Hadziyannis SJ, Tassopoulos NC, Heathcote EJ. Long term therapy with adefovir dipivoxil for HBe Ag negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006;131:1743–51.CrossRefPubMedGoogle Scholar
  29. 29.
    Seto WK, Lai CL, Fung J, Yuen J, Wong DKH, Yuen MF. A three year study on viral suppression and resistance profile for treatment naive CHB patients receiving continuous entecavir treatment. Hepatol Int. 2010;4:58.Google Scholar
  30. 30.
    Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovirdisoproxilfumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468–75.CrossRefPubMedGoogle Scholar
  31. 31.
    WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. March, 2015.Google Scholar
  32. 32.
    CDC. A compulsive immunization strategy to eliminate transmission of HBV infection in the United States. MMWR. 2005;54:1–23.Google Scholar
  33. 33.
    Bzowej NH, Hepatitis B. Therapy in pregnancy. Curr Hepat Rep. 2010;9:197–204.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Terrault NA, Jacobson IM. Treating chronic hepatitis B infection in patients, who are pregnant or are undergoing immunosuppressive chemotherapy. Semin Liver Dis. 2007;27(Suppl1):18–24.CrossRefPubMedGoogle Scholar
  35. 35.
    Poddar U, Yachha SK, Agarwal J, Krishnani N. Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon? J Viral Hepat. 2013;20:311–6.CrossRefPubMedGoogle Scholar
  36. 36.
    D’Antiga L, Aw M, Atkins M, Moorat A, Vergani D, Mieli-Vergani G. Combined lamivudine/interferon-alpha treatment in “immunotolerant” children perinatally infected with hepatitis B: a pilot study. J Pediatr. 2006;148:228–33.CrossRefPubMedGoogle Scholar
  37. 37.
    Abaalkhail F, Elsiesy H, Al Omair A, Alghamdi MY, Alalwan A, Al Masri N, et al. SASLT practice guidelines for the Management of Hepatitis B Virus. Saudi J Gastroenterol. 2014;20:5–25.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Md Rukunuzzaman
    • 1
  • Md Benzamin
    • 1
  • Kaniz Sultana
    • 2
  1. 1.Department of Paediatric Gastroenterology and NutritionBSMMUDhakaBangladesh
  2. 2.Dhaka Medical College HospitalDhakaBangladesh

Personalised recommendations